Nnamdi Njoku Biography and Net Worth

Executive Vice President, Chief Operating Officer of Omnicell

Nnamdi Njoku joined Omnicell in October 2024, bringing more than 25 years of experience in leading global operations at several global healthcare and medical technology organizations. Mr. Njoku is responsible for the Company’s global operations and continuous improvement efforts. He leads the following functions: Customer Experience and Customer Technical Services; Engineering and Product Management; Human Resources/People; Information Technology (IT); Internal Communications; Quality and Product Regulatory; Supply Chain, Logistics, and Manufacturing; Sales and Marketing; Transformation; and the Company’s Consumables, EnlivenHealth, and Specialty Pharmacy Services offerings. Prior to joining Omnicell, Mr. Njoku served as President – Sports Medicine, Surgical, Upper Extremities and Restorative Therapies of Zimmer Biomet Holdings, Inc. Prior to this, Mr. Njoku served more than 18 years in various executive leadership roles at Medtronic plc, most recently serving as Senior Vice President and President for the Neuromodulation Operating Unit, an approximately $2 billion business focused on harnessing the power of neuromodulation to treat conditions like pain and movement disorders. Throughout his career, Mr. Njoku has served in several additional operational roles of increasing responsibility, including at UnitedHealth Group and Deloitte Consulting. Mr. Njoku earned a Master of Business Administration from Cornell University and a Bachelor of Arts degree in Business Administration from the University of St. Thomas and is a Fellow of the fourth class of Aspen Institute’s Health Innovators Fellowship, a member of the Aspen Global Leadership Network.

What is Nnamdi Njoku's net worth?: The estimated net worth of Nnamdi Njoku is at least $6.48 million as of May 18th, 2026. Mr. Njoku owns 154,785 shares of Omnicell stock worth more than $6,483,944 as of June 4th. This net worth approximation does not reflect any other assets that Mr. Njoku may own. Learn More about Nnamdi Njoku's net worth.
How do I contact Nnamdi Njoku?: The corporate mailing address for Mr. Njoku and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Nnamdi Njoku's contact information.
Has Nnamdi Njoku been buying or selling shares of Omnicell?: In the last ninety days, Nnamdi Njoku has sold $133,549.80 in shares of Omnicell stock. Most recently, Nnamdi Njoku sold 3,090 shares of the business's stock in a transaction on Monday, May 18th. The shares were sold at an average price of $43.22, for a transaction totalling $133,549.80. Following the completion of the sale, the executive vice president now directly owns 154,785 shares of the company's stock, valued at $6,689,807.70. Learn More on Nnamdi Njoku's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Joanne Bauer (Director), Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Corey Manley (Executive Vice President, Chief Legal and Administrative Officer), Christine Mellon (EVP), Nnamdi Njoku (Executive Vice President, Chief Operating Officer), Mark Parrish (Director), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, insiders at the sold shares 5 times. They sold a total of 25,506 shares worth more than $1,041,309.15. The most recent insider tranaction occured on May, 18th when EVP Corey J Manley sold 5,025 shares worth more than $217,180.50. Insiders at Omnicell own 2.9% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 5/18/2026.

Nnamdi Njoku Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/18/2026	Sell	3,090	$43.22	$133,549.80	154,785

Nnamdi Njoku Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $43.54

$42.44

$43.25

50 Day Range

MA: $39.51

$32.35

$45.51

2 Week Range

Now: $43.54

$26.84

$55.00

Volume

31,563 shs

Average Volume

605,729 shs

Market Capitalization

$1.98 billion

P/E Ratio

98.67

Dividend Yield

N/A

Beta

0.97